These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 24899178

  • 21. MicroRNA-466l inhibits antiviral innate immune response by targeting interferon-alpha.
    Li Y, Fan X, He X, Sun H, Zou Z, Yuan H, Xu H, Wang C, Shi X.
    Cell Mol Immunol; 2012 Nov; 9(6):497-502. PubMed ID: 23042536
    [Abstract] [Full Text] [Related]

  • 22. Delayed translational silencing of ceruloplasmin transcript in gamma interferon-activated U937 monocytic cells: role of the 3' untranslated region.
    Mazumder B, Fox PL.
    Mol Cell Biol; 1999 Oct; 19(10):6898-905. PubMed ID: 10490627
    [Abstract] [Full Text] [Related]

  • 23. Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans.
    Currie SM, Gwyer Findlay E, McFarlane AJ, Fitch PM, Böttcher B, Colegrave N, Paras A, Jozwik A, Chiu C, Schwarze J, Davidson DJ.
    J Immunol; 2016 Mar 15; 196(6):2699-710. PubMed ID: 26873992
    [Abstract] [Full Text] [Related]

  • 24. Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus.
    Kota S, Sabbah A, Chang TH, Harnack R, Xiang Y, Meng X, Bose S.
    J Biol Chem; 2008 Aug 15; 283(33):22417-29. PubMed ID: 18567888
    [Abstract] [Full Text] [Related]

  • 25. Hu Antigen R Regulates Antiviral Innate Immune Responses through the Stabilization of mRNA for Polo-like Kinase 2.
    Sueyoshi T, Kawasaki T, Kitai Y, Ori D, Akira S, Kawai T.
    J Immunol; 2018 Jun 01; 200(11):3814-3824. PubMed ID: 29678949
    [Abstract] [Full Text] [Related]

  • 26. GBP5 Is an Interferon-Induced Inhibitor of Respiratory Syncytial Virus.
    Li Z, Qu X, Liu X, Huan C, Wang H, Zhao Z, Yang X, Hua S, Zhang W.
    J Virol; 2020 Oct 14; 94(21):. PubMed ID: 32796072
    [Abstract] [Full Text] [Related]

  • 27. Respiratory syncytial virus infection alters surfactant protein A expression in human pulmonary epithelial cells by reducing translation efficiency.
    Bruce SR, Atkins CL, Colasurdo GN, Alcorn JL.
    Am J Physiol Lung Cell Mol Physiol; 2009 Oct 14; 297(4):L559-67. PubMed ID: 19525387
    [Abstract] [Full Text] [Related]

  • 28. Identification of the RNA Pseudoknot within the 3' End of the Porcine Reproductive and Respiratory Syndrome Virus Genome as a Pathogen-Associated Molecular Pattern To Activate Antiviral Signaling via RIG-I and Toll-Like Receptor 3.
    Xie S, Chen XX, Qiao S, Li R, Sun Y, Xia S, Wang LJ, Luo X, Deng R, Zhou EM, Zhang GP.
    J Virol; 2018 Jun 15; 92(12):. PubMed ID: 29618647
    [Abstract] [Full Text] [Related]

  • 29. Transcript-selective translational silencing by gamma interferon is directed by a novel structural element in the ceruloplasmin mRNA 3' untranslated region.
    Sampath P, Mazumder B, Seshadri V, Fox PL.
    Mol Cell Biol; 2003 Mar 15; 23(5):1509-19. PubMed ID: 12588972
    [Abstract] [Full Text] [Related]

  • 30. 4(3H)-Quinazolone regulates innate immune signaling upon respiratory syncytial virus infection by moderately inhibiting the RIG-1 pathway in RAW264.7 cell.
    He L, Fan F, Hou X, Wu H, Wang J, Xu H, Sun Y.
    Int Immunopharmacol; 2017 Nov 15; 52():245-252. PubMed ID: 28957692
    [Abstract] [Full Text] [Related]

  • 31. Alternative mRNA Processing of Innate Response Pathways in Respiratory Syncytial Virus (RSV) Infection.
    Xu X, Mann M, Qiao D, Brasier AR.
    Viruses; 2021 Jan 31; 13(2):. PubMed ID: 33572560
    [Abstract] [Full Text] [Related]

  • 32. Translation control of TAK1 mRNA by hnRNP K modulates LPS-induced macrophage activation.
    Liepelt A, Mossanen JC, Denecke B, Heymann F, De Santis R, Tacke F, Marx G, Ostareck DH, Ostareck-Lederer A.
    RNA; 2014 Jun 31; 20(6):899-911. PubMed ID: 24751651
    [Abstract] [Full Text] [Related]

  • 33. IFN-γ Influences Epithelial Antiviral Responses via Histone Methylation of the RIG-I Promoter.
    Spalluto CM, Singhania A, Cellura D, Woelk CH, Sanchez-Elsner T, Staples KJ, Wilkinson TMA.
    Am J Respir Cell Mol Biol; 2017 Oct 31; 57(4):428-438. PubMed ID: 28481620
    [Abstract] [Full Text] [Related]

  • 34. Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.
    Wang S, Chi X, Wei H, Chen Y, Chen Z, Huang S, Chen JL.
    J Virol; 2014 Aug 31; 88(15):8375-85. PubMed ID: 24829357
    [Abstract] [Full Text] [Related]

  • 35. The respiratory syncytial virus fusion protein formulated with a polymer-based adjuvant induces multiple signaling pathways in macrophages.
    Sarkar I, Garg R, van Drunen Littel-van den Hurk S.
    Vaccine; 2018 Apr 19; 36(17):2326-2336. PubMed ID: 29559168
    [Abstract] [Full Text] [Related]

  • 36. Identification of cellular microRNA-136 as a dual regulator of RIG-I-mediated innate immunity that antagonizes H5N1 IAV replication in A549 cells.
    Zhao L, Zhu J, Zhou H, Zhao Z, Zou Z, Liu X, Lin X, Zhang X, Deng X, Wang R, Chen H, Jin M.
    Sci Rep; 2015 Oct 09; 5():14991. PubMed ID: 26450567
    [Abstract] [Full Text] [Related]

  • 37. Inosine-containing RNA is a novel innate immune recognition element and reduces RSV infection.
    Liao JY, Thakur SA, Zalinger ZB, Gerrish KE, Imani F.
    PLoS One; 2011 Oct 09; 6(10):e26463. PubMed ID: 22028885
    [Abstract] [Full Text] [Related]

  • 38. BRD4 Couples NF-κB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection.
    Tian B, Yang J, Zhao Y, Ivanciuc T, Sun H, Garofalo RP, Brasier AR.
    J Virol; 2017 Mar 15; 91(6):. PubMed ID: 28077651
    [Abstract] [Full Text] [Related]

  • 39. Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans.
    Sun Y, Jain D, Koziol-White CJ, Genoyer E, Gilbert M, Tapia K, Panettieri RA, Hodinka RL, López CB.
    PLoS Pathog; 2015 Sep 15; 11(9):e1005122. PubMed ID: 26336095
    [Abstract] [Full Text] [Related]

  • 40. The Interferon Type I/III Response to Respiratory Syncytial Virus Infection in Airway Epithelial Cells Can Be Attenuated or Amplified by Antiviral Treatment.
    McCutcheon KM, Jordan R, Mawhorter ME, Noton SL, Powers JG, Fearns R, Cihlar T, Perron M.
    J Virol; 2016 Feb 15; 90(4):1705-17. PubMed ID: 26608311
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.